Wills Eye Ophthalmology Clinic Inc - Philadelphia, Pennsylvania 19107

Wills Eye Ophthalmology Clinic Inc is categorized under Ophthalmologists in Philadelphia, PA .

Business Name: Wills Eye Ophthalmology Clinic Inc
Contact Person: Jeri Mogle
Address: 840 Walnut St, Philadelphia, Pennsylvania 19107
Phone Number: (215) 928-3320
Website Address: intranet.willseye.org
Annual Revenue (USD): $2.500.000 to $4.999.999
Founding Year: 2011
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Ophthalmologists
SIC Code: 8011
NAICS Code: 621111
Share This Business:
Related Businesses: Wills Eye Research Center Inc - Philadelphia, PA 19107
Corneal Associates - Philadelphia, PA 19107
Center City Opthalmology - Philadelphia, PA 19107
Ocular Oncology Service - Philadelphia, PA 19107
Neuro-Ophthalmologic - Philadelphia, PA 19107
Accuvision Eye Caregroup Pc - Philadelphia, PA 19107
Cataract & Primary Eye Care - Philadelphia, PA 19107
Willshire Hospital - Philadelphia, PA 19107
Retina Service-Wills Eye Hosp - Philadelphia, PA 19107
Ophthalmic Partners of pa - Philadelphia, PA 19107
Spaeth & Katz - Philadelphia, PA 19107
Phila Retina En - Philadelphia, PA 19107

The company Wills Eye Ophthalmology Clinic Inc provides B2C services in the form of Ophthalmologists from its single location in Pennsylvania. 1 to 4 employees work for Wills Eye Ophthalmology Clinic Inc, and the business now earns $2.500.000 to $4.999.999 per annum.

Wills Eye Ophthalmology Clinic Inc was launched in 2011 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 . To contact Wills Eye Ophthalmology Clinic Inc, please call Jeri Mogle with the phone number (215) 928-3320 or visit its single location at 840 Walnut St in Philadelphia, Pennsylvania 19107.

The location of the single location can also be found using the coordinates 39.94805,-75.155062. Read more details about this business on the webpage intranet.willseye.org or follow the company’s social media accounts, on Twitter and on Facebook.